| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/26/1986 | EP0175274A2 Method of separation of blood components |
| 03/26/1986 | EP0175266A2 Antihypertensive derivatives |
| 03/26/1986 | EP0174993A1 Bone protein purification process |
| 03/26/1986 | EP0174979A1 Method of lowering blood sugar level in vertebrates |
| 03/26/1986 | EP0174957A1 Method of treating memory disorders of the elderly |
| 03/25/1986 | US4578361 Creatinine antibody |
| 03/25/1986 | US4578219 Contraceptive vaccine |
| 03/25/1986 | US4578218 Purification of factor VIII with insoluble matrix having free sulfate groups covalently bound thereto |
| 03/25/1986 | CA1202261A1 A47934 antibiotic and its production |
| 03/25/1986 | CA1202256A2 Microbial expression of quasi-synthetic genes |
| 03/19/1986 | EP0174874A2 Hybrid cell line producing monoclonal antibody cytolytic to trichomonas vaginalis |
| 03/19/1986 | EP0174737A2 Treatment of collagenous tissue |
| 03/19/1986 | EP0174704A2 Composition for protecting teeth against decalcification |
| 03/19/1986 | EP0174669A2 Process for the production of a hybrid DNA containing the complementary hepatitis A virus genome, this hybrid DNA and plasmid vector containing it, virus-specific proteins expressed by this hybrid DNA, vaccines containing and produced from these proteins |
| 03/19/1986 | EP0174571A2 Derivatives of amino acids, process for their preparation and pharmaceutical compositions |
| 03/18/1986 | US4576932 Dietary supplement and method |
| 03/18/1986 | US4576914 Method for enhancing a fungus-lytic activity of β-1,3-D-glucanase |
| 03/18/1986 | US4576696 Process for the preparation of a biologically active extract |
| 03/18/1986 | EP0162078A4 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein. |
| 03/13/1986 | WO1986001538A1 Modified tissue plasminogen activators |
| 03/13/1986 | WO1986001535A1 Molecular clones of the genome of htlv-iii |
| 03/13/1986 | WO1986001532A1 Polypeptide and polypeptide composition |
| 03/13/1986 | WO1986001516A1 Cyclic polypeptides having mu-receptor specificity |
| 03/13/1986 | WO1986001515A1 Expression of human connective tissue activator and related peptides |
| 03/13/1986 | WO1986001409A1 Acid-cleavable compound |
| 03/13/1986 | WO1986001408A1 Antiviral peptides |
| 03/13/1986 | WO1986001407A1 Monoclonal antibodies against metal chelates |
| 03/12/1986 | EP0174279A2 Improvements in relation to cyclosporin therapy |
| 03/12/1986 | EP0174245A1 Medicaments containing tripeptides |
| 03/12/1986 | EP0174204A2 Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof |
| 03/12/1986 | EP0174175A2 A process for preparing malleable collagen and the product thereof |
| 03/12/1986 | EP0174162A2 Pharmaceutically active dipeptide derivatives |
| 03/12/1986 | EP0174143A1 Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and DNA and transfected hosts therefor |
| 03/12/1986 | EP0174129A1 Isopenicillin N derivatives, their preparation and use and intermediates therefor |
| 03/12/1986 | EP0173997A1 Feline leukemia virus protein vaccines and their preparation |
| 03/12/1986 | EP0173960A2 Muramylpeptide active ester derivatives |
| 03/12/1986 | EP0173951A2 Tumour therapeutic agent and process for its preparation |
| 03/12/1986 | EP0173944A2 Enhanced inhibition of yeast cell growth |
| 03/12/1986 | EP0173924A2 Mechanical process for dislodging bacterial cells for the isolation of peptides prepared by recombinant techniques |
| 03/12/1986 | EP0173887A1 Novel interferon alphas |
| 03/11/1986 | US4575503 Angiotensin converting enzyme inhibitor, hypotensive |
| 03/11/1986 | US4575489 Streptomyces albulus subsp. ochragerus subsp. nov. culture for making peptide |
| 03/11/1986 | US4575459 Immunotherapy |
| 03/11/1986 | CA1201710A1 Analgesic compounds |
| 03/05/1986 | EP0173663A2 The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases |
| 03/05/1986 | EP0173648A2 New monoclonal antibodies to glycoconjugates, processes for their production, and applications |
| 03/05/1986 | EP0173557A2 Peptides |
| 03/05/1986 | EP0173529A1 Molecular clones of the genome of HTLV-III |
| 03/05/1986 | EP0173527A2 Insulin-selective somatostatin analogs |
| 03/05/1986 | EP0173510A2 Tripeptide derivatives for use as anti-hypertensive agents |
| 03/05/1986 | EP0173494A2 Chimeric receptors by DNA splicing and expression |
| 03/05/1986 | EP0173481A2 Peptides |
| 03/05/1986 | EP0173384A2 Polypeptide relating to alpha-hANP |
| 03/05/1986 | EP0173280A1 Plasmids containing lambda Pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, hosts containing the plasmids and related methods |
| 03/05/1986 | EP0173254A1 DNA sequences of the EBV genome, recombinant DNA molecules, processes for producing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens |
| 03/05/1986 | EP0173242A2 Process for the production of a pasteurized isoagglutinin-free Faktor VIII preparation from a cryoprecipitate. |
| 03/05/1986 | EP0173215A2 Method for recovering purified growth hormones from genetically engineered microorganisms |
| 03/05/1986 | EP0173145A2 Reduction of the toxic effects caused by anthraquinone drugs |
| 03/05/1986 | EP0173092A2 Anti viral composition |
| 03/05/1986 | EP0172873A1 An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions. |
| 03/04/1986 | CA1201396A1 Process for the preparation of permanent animal and human cell lines and their use |
| 03/04/1986 | CA1201385A1 Elemental diets for liver diseases |
| 02/27/1986 | WO1986001229A1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby |
| 02/27/1986 | WO1986001226A1 Fish calcitonin derivative, process for its preparation, and gene system therefor |
| 02/27/1986 | WO1986001222A1 New hybride cells secreting anti-idiotypic antibodies, new monoclonal antibodies secreted by said hybride cells, preparation and application thereof |
| 02/27/1986 | WO1986001212A1 Minactivin |
| 02/27/1986 | WO1986001211A1 Immunotherapeutic polypeptide agents |
| 02/27/1986 | WO1986001120A1 Injection method and apparatus with electrical blood absorbing stimulation |
| 02/27/1986 | WO1986001118A1 Initiating reperfusion treatment when heart attack symptoms are present |
| 02/27/1986 | WO1986001111A1 Angiogenic factor and method for producing angiogenesis |
| 02/27/1986 | WO1986001110A1 Absorption enhancing agents |
| 02/27/1986 | WO1986001109A1 Protein absorption enhancing agents |
| 02/27/1986 | WO1986001105A1 Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 02/27/1986 | WO1986001104A1 t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM |
| 02/26/1986 | EP0172710A2 Hemostatic agent |
| 02/26/1986 | EP0172581A2 Disaccharide derivatives |
| 02/26/1986 | EP0172577A1 A superoxide dismutase, its production and pharmaceutical compositions containing it |
| 02/26/1986 | EP0172559A2 Polysaccharide RON substance, production of the same and use of the same |
| 02/26/1986 | EP0172422A2 Microcapsules of regulatory peptides with controlled release, their preparation and injectable formulations |
| 02/26/1986 | EP0172361A2 Cloned cardionatrin cDNA, cleaved cardionatrin cDNA and cardionatrin precursors, their preparation, corresponding plasmids and microorganisms comprising said plasmid |
| 02/26/1986 | EP0172347A2 Renin inhibiting compounds |
| 02/26/1986 | EP0172346A2 Renin inhibiting compounds |
| 02/26/1986 | EP0172166A1 Enzyme-containing digestive aid compositions |
| 02/26/1986 | EP0058665B1 Carbohydrate derivatives for inhibiting bacterial adherence |
| 02/25/1986 | US4572834 Biologic and method of preparing same |
| 02/19/1986 | EP0172045A1 Antitumour glycoproteins modified at their carbohydrate moieties, and process for obtaining them |
| 02/19/1986 | EP0172007A2 Stable liposomes with aqueous-soluble medicaments and methods for their preparation |
| 02/19/1986 | EP0171908A2 Hepatitis B virus surface antigen and production thereof |
| 02/19/1986 | EP0171887A2 Anti-diabetic compounds |
| 02/19/1986 | EP0171886A2 Anti-diabetic compounds |
| 02/19/1986 | EP0171496A2 Process for the production of a chimera monoclonal antibody |
| 02/19/1986 | EP0171477A2 Amino acid-containing therapeutic compounds |
| 02/18/1986 | US4571391 For treating diabetes; in conjunction with insulin therapy |
| 02/18/1986 | US4571336 Immune stimulation |
| 02/18/1986 | CA1200772A1 Expression vectors of catechol 2,3-oxygenase, enzymes thus obtained and uses thereof |
| 02/18/1986 | CA1200763A1 Medicinal composition for the treatment of certain neuroviroses |
| 02/13/1986 | WO1986000930A1 Retroviral vaccines and vectors and methods for their construction |
| 02/13/1986 | WO1986000909A1 Monoclonal antibody directed to human ganglioside gd2 |
| 02/13/1986 | WO1986000810A1 Total parenteral and enteral nutrition composition |
| 02/12/1986 | EP0171315A1 Process for the synthesis of hGRF (Somatocrinin) in the liquid phase, and intermediary peptides |